602 related articles for article (PubMed ID: 30428011)
1. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.
Hausenloy DJ; Chilian W; Crea F; Davidson SM; Ferdinandy P; Garcia-Dorado D; van Royen N; Schulz R; Heusch G
Cardiovasc Res; 2019 Jun; 115(7):1143-1155. PubMed ID: 30428011
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
Jaffe R; Dick A; Strauss BH
JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
[TBL] [Abstract][Full Text] [Related]
3. Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection.
Hausenloy DJ; Bøtker HE; Ferdinandy P; Heusch G; Ng GA; Redington A; Garcia-Dorado D
Cardiovasc Res; 2019 Jun; 115(7):1167-1177. PubMed ID: 30796814
[TBL] [Abstract][Full Text] [Related]
4. The coronary circulation in cardioprotection: more than just one confounder.
Heusch G; Kleinbongard P; Skyschally A; Levkau B; Schulz R; Erbel R
Cardiovasc Res; 2012 May; 94(2):237-45. PubMed ID: 22002502
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity as a target for acute cardioprotection.
Zuurbier CJ; Abbate A; Cabrera-Fuentes HA; Cohen MV; Collino M; De Kleijn DPV; Downey JM; Pagliaro P; Preissner KT; Takahashi M; Davidson SM
Cardiovasc Res; 2019 Jun; 115(7):1131-1142. PubMed ID: 30576455
[TBL] [Abstract][Full Text] [Related]
6. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.
Andreadou I; Cabrera-Fuentes HA; Devaux Y; Frangogiannis NG; Frantz S; Guzik T; Liehn EA; Gomes CPC; Schulz R; Hausenloy DJ
Cardiovasc Res; 2019 Jun; 115(7):1117-1130. PubMed ID: 30825305
[TBL] [Abstract][Full Text] [Related]
7. Reducing myocardial infarct size: challenges and future opportunities.
Bulluck H; Yellon DM; Hausenloy DJ
Heart; 2016 Mar; 102(5):341-8. PubMed ID: 26674987
[TBL] [Abstract][Full Text] [Related]
8. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
Hale SL; Mehra A; Leeka J; Kloner RA
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H421-5. PubMed ID: 17993599
[TBL] [Abstract][Full Text] [Related]
9. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
Monassier JP
Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
[TBL] [Abstract][Full Text] [Related]
10. Critical Issues for the Translation of Cardioprotection.
Heusch G
Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
[TBL] [Abstract][Full Text] [Related]
11. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
Heusch G
Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
[TBL] [Abstract][Full Text] [Related]
13. Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning.
Skyschally A; Walter B; Heusch G
Eur Heart J; 2013 Nov; 34(42):3314-21. PubMed ID: 23242190
[TBL] [Abstract][Full Text] [Related]
14. Shining the spotlight on cardioprotection: beyond the cardiomyocyte.
Davidson SM; Andreadou I; Garcia-Dorado D; Hausenloy DJ
Cardiovasc Res; 2019 Jun; 115(7):1115-1116. PubMed ID: 30865272
[No Abstract] [Full Text] [Related]
15. The Coronary Circulation as a Target of Cardioprotection.
Heusch G
Circ Res; 2016 May; 118(10):1643-58. PubMed ID: 27174955
[TBL] [Abstract][Full Text] [Related]
16. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
Ovize M; Baxter GF; Di Lisa F; Ferdinandy P; Garcia-Dorado D; Hausenloy DJ; Heusch G; Vinten-Johansen J; Yellon DM; Schulz R;
Cardiovasc Res; 2010 Aug; 87(3):406-23. PubMed ID: 20448097
[TBL] [Abstract][Full Text] [Related]
17. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
[TBL] [Abstract][Full Text] [Related]
18. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE
Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning and postconditioning: underlying mechanisms and clinical application.
Hausenloy DJ; Yellon DM
Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
[TBL] [Abstract][Full Text] [Related]
20. Ischaemic conditioning and reperfusion injury.
Hausenloy DJ; Yellon DM
Nat Rev Cardiol; 2016 Apr; 13(4):193-209. PubMed ID: 26843289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
